Effects of Salmon Calcitonin on the Concentrations of Monoamines in Periaqueductal Gray in Formalin Test

Background: The receptors of salmon calcitonin, located on certain areas of the brain such as the periaqueductal gray matter, are responsible for pain modulation. Aims: The effects of intracerebroventricular injection of salmon calcitonin on the behavioral response to pain and on the levels of mono...

Full description

Bibliographic Details
Published in:	Balkan Medical Journal
Main Authors:	Kaveh Rahimi, Javad Sajedianfard, Ali Akbar Owji
Format:	Article
Language:	English
Published:	Trakya University 2019-09-01
Subjects:	Chromatography formalin test high-performance liquid microdialysis monoamine oxidase
Online Access:	http://balkanmedicaljournal.org/text.php?lang=en&id=2106

Similar Items

The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test
by: Shima Balali Dehkordi, et al.
Published: (2019-08-01)

Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
by: Edward E. Putnins, et al.
Published: (2021-11-01)

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
by: Tapan Behl, et al.
Published: (2021-06-01)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
by: Rajbir Singh, et al.
Published: (2020-06-01)

Dopamine Release in the Ventromedial Hypothalamus of Growing Chickens Decreases when They are Fed a Lysine Devoid Diet
by: Aki Ichijo, et al.
Published: (2008-10-01)

Inhibition of Monoamine Oxidases by Pyridazinobenzylpiperidine Derivatives
by: Jong Min Oh, et al.
Published: (2024-06-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

An investigation of the monoamine oxidase inhibition properties of benzothiazole derivatives
by: Anandie le Roux, et al.
Published: (2025-03-01)

Brain Microdialysate Monoamines in Relation to Circadian Rhythms, Sleep, and Sleep Deprivation – a Systematic Review, Network Meta-analysis, and New Primary Data
by: Julia M. L. Menon, et al.
Published: (2019-01-01)

Selective Interactions of <i>O</i>-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
by: Narayan D. Chaurasiya, et al.
Published: (2020-11-01)

Allelic Diversity of VNTR Polymorphism in Monoamine Oxidase A (MAOA) Gene in Young Women and Men in Mashhad, Iran
by: Sedigheh Sadat Hojjati, et al.
Published: (2020-02-01)

Long-term exposure to xenoestrogens alters some brain monoamines and both serum thyroid hormones and cortisol levels in adult male rats
by: Nashwa M. Saied, et al.
Published: (2014-10-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
by: Chung-Chieh Hung, et al.
Published: (2024-01-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)

Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)

In silico Investigation of the Anticancer Activity of Natural Isoquinoline Alkaloids Targeting the Monoamine Oxidase a Enzyme
by: Reham A.Al-Anssari, et al.
Published: (2025-08-01)

Green Oxidation of Amines by a Novel Cold-Adapted Monoamine Oxidase MAO P3 from Psychrophilic Fungi <i>Pseudogymnoascus</i> sp. P3
by: Iga Jodłowska, et al.
Published: (2021-10-01)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
by: Wiem Haj Ahmed, et al.
Published: (2020-04-01)

Small molecule probes for the specific imaging of monoamine oxidase A and monoamine oxidase B
by: Yi Fang, et al.
Published: (2024-04-01)

Synthesis of 1,2,4-Oxadiazin-5(6<i>H</i>)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors
by: Sofia I. Presnukhina, et al.
Published: (2024-11-01)

Monoamine oxidases: A missing link between mitochondria and inflammation in chronic diseases ?
by: Lise Beucher, et al.
Published: (2024-11-01)

Molecular docking, drug-likeness properties, and toxicity prediction of alkaloidal phytoconstituents of piper longum against monoamine oxidase enzyme-A as an anti-depressive agent
by: Santosh Prasad Chaudhary kurmi, et al.
Published: (2025-05-01)

Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
by: Jiseong Lee, et al.
Published: (2024-01-01)

Synthesis, biochemistry, and in silico investigations of isatin-based hydrazone derivatives as monoamine oxidase inhibitors
by: Naseer Maliyakkal, et al.
Published: (2024-07-01)

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson’s Disease: An Update
by: Luana Vergueiro Ribeiro, et al.
Published: (2025-10-01)

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Sex-Specific Effects of Early Life Stress on Brain Mitochondrial Function, Monoamine Levels and Neuroinflammation
by: Héctor González-Pardo, et al.
Published: (2020-07-01)

Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B
by: Narayan D. Chaurasiya, et al.
Published: (2021-04-01)

Susceptibility to methamphetamine dependence associated with high transcriptional activity alleles of VNTR polymorphism in the promoter region of monoamine oxidase A (MAOA)
by: Khyber Saify, et al.
Published: (2016-01-01)

Association of Monoamine Oxidase A Gene Promoter Region (30 bp μVNTR) Polymorphism with Serum Levels in Multiple Psychiatric Disorders
by: Aisha Nasir Hashmi, et al.
Published: (2025-03-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
by: Huang ST, et al.
Published: (2024-01-01)

Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
by: Aathira Sujathan Nair, et al.
Published: (2021-05-01)

Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives
by: Adel Amer, et al.
Published: (2020-04-01)

Design, Synthesis, Biological Evaluation, and In Silico Study of Tetrahydropyridines as Prospective Monoamine Oxidase Inhibitors
by: Dr. Obaid ur Rehman Khan, et al.
Published: (2025-10-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs
by: Stefano Cagnin, et al.
Published: (2022-08-01)

Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation
by: Arshida Thottile Peedikayil, et al.
Published: (2023-10-01)

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
by: Ilana Berlowitz, et al.
Published: (2022-05-01)

Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B
by: Zhuo Kong, et al.
Published: (2020-01-01)